Assignee
IMMUSANT INC
US·4 granted patents·16 pending applications·8 citations·filing 2013–2020
Top patents by PatentIndex Score
20 records- 0182US9464120B2Compositions for treatment of celiac diseaseIMMUSANT INC·Filed 2014·Granted Oct 11, 2016·6 cites·21 claims
- 0278US10473647B1Peptides for use in treatment and diagnosis of type 1 diabetesIMMUSANT INC·Filed 2015·Granted Nov 12, 2019·2 cites·12 claims
- 0366US2020141924A1Peptides for use in treatment and diagnosis of type 1 diabetesIMMUSANT INC·Filed 2019·Application pending·0 cites
- 0465US2021115096A1Compositions and methods for treatment of celiac diseaseIMMUSANT INC·Filed 2020·Application pending·0 cites
- 0563US2020024664A1Use of hla genetic status to assess or select treatment of celiac diseaseIMMUSANT INC·Filed 2019·Application pending·0 cites
- 0658US10449228B2Dosage of a gluten peptide compositionIMMUSANT INC·Filed 2014·Granted Oct 22, 2019·0 cites·21 claims
- 0758US10370718B2Use of HLA genetic status to assess or select treatment of celiac diseaseIMMUSANT INC·Filed 2015·Granted Aug 6, 2019·0 cites·13 claims
- 0858US2019048047A1Compositions and methods for treatment of celiac diseaseIMMUSANT INC·Filed 2018·Application pending·0 cites
- 0953US2017158743A1Compositions and methods for treatment of celiac diseaseIMMUSANT INC·Filed 2016·Application pending·0 cites
- 1051US2020397852A1Dosing regimens for celiac diseaseIMMUSANT INC·Filed 2020·Application pending·0 cites
- 1150US2017045513A1Methods of diagnosing celiac disease using ip-10IMMUSANT INC·Filed 2015·Application pending·0 cites
- 1250US2017042991A1Compositions comprising gluten peptides and uses thereofIMMUSANT INC·Filed 2015·Application pending·0 cites
- 1350US2017045529A1Methods of measuring antigen-specific t cellsIMMUSANT INC·Filed 2015·Application pending·0 cites
- 1448US2016041148A1Placebo-controlled gluten challenge methodIMMUSANT INC·Filed 2014·Application pending·0 cites
- 1547US2017232083A1Methods of diagnosis and treatment of celiac disease in childrenIMMUSANT INC·Filed 2015·Application pending·0 cites
- 1645US2019224276A1Escalating dosage schedules for treating celiac diseaseIMMUSANT INC·Filed 2017·Application pending·0 cites
- 1744US2016238590A1Compositions and methods related to oat sensitivityIMMUSANT INC·Filed 2013·Application pending·0 cites
- 1842US2019204341A1Compositions and methods for diagnosing celiac disease using circulating cytokines/chemokinesIMMUSANT INC·Filed 2017·Application pending·0 cites
- 1937US2017059582A1Methods for diagnosing celiac disease using circulating cytokines/chemokinesIMMUSANT INC·Filed 2015·Application pending·0 cites
- 2037US2017097346A1Use of interleukin-2 for diagnosis of celiac diseaseIMMUSANT INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUSANT INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →